admitted to an anxiety disorders treatment clinic serving a disadvantaged urban population. A standardized set of interviews was administered to 42 subjects, 31 with PAD and 11 without PAD (NPAD ...
Silo Pharma (NASDAQ: SILO) received a Notice of Allowance from the U.S. Patent and Trademark Office for a key patent supporting its lead asset, SPC- ...